Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jiangniaosuan formula plus febuxostat for hyperuricemia
ChiCTR2000041083Phase 4Not yet recruiting
- Sponsor
- Shanghai Pudong Hospital
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of febuxostat and Jiangniaosuan formula in hyperuricemia and gout (2 arms), sponsored by Shanghai Pudong Hospital. Primary endpoints: Serum uric acid and TCM syndrome score. Planned start Jan 2021; status: not yet recruiting.
02
Drugs
febuxostatJiangniaosuan formula
03
Conditions
hyperuricemiagout
Beyond the preview
Go deeper on ChiCTR2000041083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000041083.